
Join to View Full Profile
UH Cleveland Medical Center11100 Euclid Ave Department of Medicine-Hematology and OncologyCleveland, OH 44106
Phone+1 216-844-3951
Fax+1 216-844-5234
Dr. Montero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve UniversityMPOD, Organizational Development , 2024 - 2026
University of Miami School of BusinessMBA, 2011 - 2013
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1999 - 2002
University of Texas Medical Branch School of MedicineClass of 1999
University of Texas at Austin Dell Medical SchoolB.A., Summa Cum Laude, 1990 - 1994
Certifications & Licensure
DE State Medical License 2025 - 2027
TX State Medical License 2002 - 2027
FL State Medical License 2008 - 2026
IL State Medical License 2025 - 2026
OH State Medical License 2013 - 2026
PA State Medical License 2025 - 2026
SC State Medical License 2005 - 2009
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Clinical Director, Breast Cancer Medical Oncology Program University Hospitals, 2020
- Six Sigma Green Belt University of Miami School of Business, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer Start of enrollment: 2007 Jun 04
- Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Deconstructing racial disparities in timely treatment of triple-negative breast cancer: A causal mediation analysis.Trisha Lal, Richard S Hoehn, Alberto J Montero, Amanda L Amin
American Journal of Surgery. 2025-10-03 - A Review of Current Literature and Real-World Outcomes With Neoadjuvant Chemotherapy in Hormone Receptor Positive, HER2 Negative Breast Cancer.Gregory Guzik, Matthew Kurian, Kanchi Patell, Marcus Trybula, Pingfu Fu
Clinical Breast Cancer. 2025-07-01 - 2 citationsA Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor-Positive Breast Cancer: The BRACELE...Amy S Clark, Fengmin Zhao, Paula Klein, Alberto J Montero, Carla Falkson
Clinical Cancer Research. 2025-07-01
Journal Articles
- Re: Xie, J, Diener M, De G et al Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative...Diaby V, Adunlin G, Montero AJ, J Med Econ, 2/10/2014
- Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62LDiaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ , Lichtenheld MG, Immunol Res, 11/12/2013
- Breast Cancer Survival Poorer in Black Women: CommentaryMontero AJ, Healio/HemOnc Today, 8/1/2013
- Join now to see all
Authored Content
- Everywhere Winds: Pandemic Haiku for the SpiritMarch 2022
- We Don't Have All the Answers, and We Don't Have ToMay 2021
Press Mentions
ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast CancerDecember 10th, 2024
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab Will Be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024November 1st, 2024
What Is Metastatic Breast Cancer? Doctors Explain the Advanced Form of the DiseaseSeptember 14th, 2021- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









